Senior biopharmaceutical executive with 25+ years of leadership experience in Clinical Development, R&D, and Global Clinical Operations, including multiple Global Vice President-level roles.
Proven track record leading large-scale global organizations of more than 1,000 FTEs across EMEA, APAC, and LATAM, with operational responsibility spanning 40+ countries.
Extensive expertise across the full Clinical Operations spectrum, including site recruitment and engagement, study start-up, monitoring, quality oversight, global project management, vendor management, contracting and budgeting, payments, insurance, clinical supplies, eTMF, and CTMS.
Broad therapeutic and development experience across all clinical phases (I-IV) and multiple therapeutic areas, including Cardiovascular, Renal, Oncology, Women’s Health, Immunology, Neurology, Rare Diseases, and Cell & Gene Therapy (CGT).
Recognized leader in organizational transformation, successfully redesigning operating models, streamlining organizational structures, and introducing AI-enabled processes, resulting in a 25% productivity improvement.
Demonstrated success in enhancing site engagement and customer satisfaction, contributing to industry-leading recognition, including #1 ranking in the 2025 CenterWatch Site Relationship Survey and the 2026 SCRS Eagle Award.
Strong reputation for change leadership, operational excellence, talent development, and team empowerment in complex global environments